Dossier d'AMM à évaluer par la Commission Spécialisée de Pneumologie Allergologie, Anesthésie Et Réanimation et des Médicaments Correcteurs des Troubles Cardiovasculaires du 31/01/2023
N° | NOM | DCI | DOSAGE | FORME | PRESENTATION | G/P | LABORATOIRE | Motif |
Anesthésie Réa | ||||||||
1 | TISSEL LYO | Fibrinogene+Aprotinine+Thrombine Hulaine+Chlorure de Calcium | 91mg1 / 3000KIU/500 ui /400 µmol | Pdre et slvt Pour colle | B/1/2 ML | P | BAXTER Gmbh | AMM |
2 | TISSEL LYO | Fibrinogene+Aprotinine+Thrombine Hulaine+Chlorure de Calcium | 91mg1 / 3000KIU/500 ui /400 µmol | Pdre et slvt Pour colle | B/1/4 ML | P | BAXTER Gmbh | AMM |
3 | TISSEL LYO | Fibrinogene+Aprotinine+Thrombine Hulaine+Chlorure de Calcium | 91mg1 / 3000KIU/500 ui /400 µmol | Pdre et slvt Pour colle | B/1/10 ML | P | BAXTER Gmbh | AMM |
4 | Chlorure de Sodium | Chlorure de Sodium | 10% | solution injectable | B/10/10ML | G | UNIMED | indications |
5 | Chlorure de Sodium | Chlorure de Sodium | 10% | solution injectable | B/100/10ML | G | UNIMED | indications |
6 | Lidoca | Lidocaine | 1% | solution injectable | B/5 AMP | G | STERIPHARM | indications |
7 | Lidoca | Lidocaine | 2% | solution injectable | B/5 AMP | G | STERIPHARM | indications |
8 | ROPIVACAINE KABI | ROPIVACAINE | 5 mg/ml, | solution injectable en ampoule. | G | KABI | indications | |
9 | ROPIVACAINE KABI | ROPIVACAINE | 7.5 mg/ml, | solution injectable en ampoule. | . | G | KABI | indications |
10 | Unicaine | chlorhydrate de lidocaine | 1% | ampoule | B/10 | G | unimed | indications |
11 | Unicaine | chlorhydrate de lidocaine | 2% | ampoule | B/10 | G | unimed | indications |
Cardiologie | ||||||||
12 | Amlopril | ramipril+amlodipine | 5mg/5mg | gelule | B/30 | G | ACT Pharma | AMM |
13 | Amlopril | ramipril+amlodipine | 10mg/10mg | gelule | B/30 | G | ACT Pharma | AMM |
14 | Amlopril | ramipril+amlodipine | 5mg/10mg | gélules | B/30 | G | ACT Pharma | AMM |
15 | Amlopril | ramipril+amlodipine | 10mg/5 mg | gelules | B/30 | G | ACT Pharma | AMM |
16 | Bisocor | Bisoprolol | 1.25 MG | cp | B/30 | PHARMACARETunisie | AMM | |
17 | Cardensiel | BISOPROLOL | 1.25 mg | cp | B/30 | P | Merck Santé SAS France | AMM |
18 | Cardiocine | acide acetylsalicylique | 160mg | cp sec | B/30 | G | ACT Pharma | AMM |
19 | DOXINE | doxazosine | 4 mg | comprimé | B/30 | P | Pfizer INC USA | AMM |
20 | EDARBI | Azilsartan medoxomil | 40 mg | Comprimé | B/28 | G | APM-Jordanie | AMM |
21 | EDARBI | Azilsartan medoxomil | 80 mg | Comprimé | B/28 | G | APM-Jordanie | AMM |
22 | Edarbyclor | azilsartan medoxomil/chlorthalidone | 40/12,5mg | comprimé | B/28 | G | APM-Jordanie | AMM |
23 | Edarbyclor | azilsartan medoxomil/chlorthalidone | 40/25mg | comprimé | B/28 | G | APM-Jordanie | AMM |
24 | EZETILIPL | EZETIMIBE | 10 mg | cp | B/30 | G | PHARMAGHREB-Tunisie | AMM |
25 | Pemzek | Candesartan | 16mg | comprimé | B/28 | P | Astra Zeneca Suisse | AMM |
26 | Pemzek | Candesartan | 8 mg | comprimé | B/28 | P | Astra Zeneca Suisse | AMM |
27 | THERAGLOR | TICAGRELOR | 60 MG | comprimé | B/60 | G | THERA | AMM |
28 | Verquvo | Vericiguat | 2,5 mg | comprimé | B/14 | P | Bayer | AMM |
29 | Verquvo | Vericiguat | 5 MG | comprimé | B/14 | P | Bayer | AMM |
30 | Verquvo | Vericiguat | 10 mg | comprimé | B/14 | P | Bayer | AMM |
31 | Verquvo | Vericiguat | 10 mg | comprimé | B/98 | P | Bayer | AMM |
32 | Cloven | clopidogrel | 75mg | comprimé | B/30 | G | Philadelphia Pharma | Indications |
33 | Cloven | clopidogrel | 75mg | comprimé | B/90 | G | Philadelphia Pharma | indications |
34 | ENAPRIL 20 MG | ENALAPRIL | 20 MG | CP | B/30 | G | ADWYA | indications |
35 | ENAPRIL 5 MG | ENALAPRIL | 5 MG | CP | B/30 | G | ADWYA | indications |
36 | EVOCOR | BISOPROLOL | 5MG | CP | B/30 | G | Philadelphia Pharma | indications |
37 | EVOCOR | BISOPROLOL | 5 MG | CP | B/90 | G | Philadelphia Pharma | indications |
38 | EVOCOR | BISOPROLOL | 10MG | CP | B/30 | G | Philadelphia Pharma | indications |
39 | EVOCOR | BISOPROLOL | 10MG | CP | B/90 | G | Philadelphia Pharma | indications |
40 | EVOCOR | BISOPROLOL | 2.5 MG | CP | B/30 | G | Philadelphia Pharma | indications |
41 | EVOCOR | BISOPROLOL | 2.5 MG | CP | B/30 | G | Philadelphia Pharma | indications |
42 | EZEMIB | EZETIMIBE | 10mg | cp | B/30 | G | THERA | Indications |
43 | Jardiance | empagliflozine | 10 mg | comprimé | B/30 | P | Boehringer Ingelhei Allemagne | indications |
44 | Jardiance | empagliflozine | 25 mg | comprimé | B/30 | P | Boehringer Ingelhei Allemagne | indications |
45 | Pemzek PLUS | Candesartan+Hydrochlorothiazide | 8 mg/12.5 MG | comprimé | B/28 | P | Astra Zeneca Suisse | indications |
46 | Pemzek PLUS | Candesartan+Hydrochlorothiazide | 16mg/12.5 MG | comprimé | B/28 | P | Astra Zeneca Suisse | indications |
Pneumologie | ||||||||
47 | Beclonil 250 | BECLOMETHASONE | 250µg | sol pr inhalation | FL/200 doses | G | VAGA TUNISE | AMM |
48 | Bufomix EASYHEALER | BUDOSENIDE+FPRMOTEROL | 400 µg/12µg | PRDE PR INH | FL/60 doses | G | Hikma - Jordanie | AMM |
49 | Bufomix EASYHEALER | BUDOSENIDE+FPRMOTEROL | 200µg/6µg | PRDE PR INH | FL/60 doses | G | Hikma - Jordanie | AMM |
50 | Cortis | béclométhasone dipropionate | 100µg/dose | sol pr inhalation | aérosol doseur de 100 doses | G | Berg Life Sciences | Indications |
51 | Betanyl | Terbutaline | 5 MG/2ML | sol pr inhalation | B/5 sachets/10 UNIDOSES | G | UNIMED | indications |